Dr Costa: Private Children's Allergy Clinic
  • Home
  • About
  • Services
    • Types of Allergy
    • Fees
  • Resources
  • Blog
  • Contact

Allergy Articles & Updates

peanut allergy

8/10/2020

0 Comments

 
Peanut Allergy
The incidence of peanut allergy has been increasing significantly in developed countries.

Many reasons have been found for such growth, but so far no proper treatment has been found to deal with it.

Often, antihistamines are the first choice when there is an allergic reaction, with the occasional need to use adrenaline as well.

Most of the symptoms start in childhood and persists throughout life.

Due to this, the search for ways to deal with this specific allergy is ongoing, though not matching current needs.
















As such, today, I will focus on a promising medication that might lead to a significant change in the way we deal with peanut, and possibly nut, allergy.

⚠️On a Phase 2a randomized placebo control trial, running for six weeks, a single injection of Etokimab showed that it could desensitize peanut allergic adults.
➡️Food challenges, skin prick tests and blood tests were done at day 15 and 45, after injection
➡️73% (first challenge) and 57% (second challenge) passed a food challenge with 275mg of peanut protein (versus 0% in the control group)
➡️Several immune mediators were also reduced

❗They concluded that it could potentially desensitize peanut-allergic participants and possibly reduce atopy-related adverse events.

❓I understand the first part, but what is the connection to atopy?
Let me explain.
🔸️IL33 belongs to a group of proteins (cytokines) important in cell signalling (basically part of the immune cascade).
🔸️It also belongs to a small group called alarmins, which are biomolecules that can initiate and maintain a non-infectious inflammatory response (like in allergies).
🔸️It is also known to be released or elevated when there is skin damage, like in atopic dermatitis or eczema (independently of its origin).

▶️Can you see me coming again to the top priority of maintaining the skin barrier to prevent allergy?◀️

⚠️My opinion about it:
  1. Sounds quite good
  2. Need to wait for phase 3 trials
  3. Need to wait for long term follow-ups, with more food challenges and blood tests to see if tolerance is maintained

How does it compare to the current two available oral peanut immunotherapy?

CA002 (Cambridge) and AR101 (London)
🔹️Both use an “up-dosing” programme to achieve a specific tolerable dose (1600mg for the former and 600mg for the latter).
🔹️AR101 had limitations, like participants being selected based on sensitivity to a maximum of 100 mg of peanut protein.
🔹️This does not represent the entire population with peanut allergies, half of whom have reactions to doses >100 mg.

⚠️Michael R. Perkin, Consultant Paediatric Allergist PhD, wrote that the major concern regarding this immunotherapy is that 𝐚𝐥𝐥𝐞𝐫𝐠𝐞𝐧 𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝐢𝐬 𝐢𝐧𝐝𝐮𝐜𝐞𝐝 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐭𝐞𝐦𝐩𝐨𝐫𝐚𝐫𝐲, 𝐚𝐧𝐝 𝐥𝐨𝐬𝐭 𝐢𝐟 𝐫𝐞𝐠𝐮𝐥𝐚𝐫 𝐜𝐨𝐧𝐬𝐮𝐦𝐩𝐭𝐢𝐨𝐧 𝐜𝐞𝐚𝐬𝐞𝐬.⁣
⁣
▶️Neither groups have attempted to establish the duration for which allergen tolerance is maintained in the absence of ongoing consumption, potentially lifelong, 𝐫𝐞𝐠𝐮𝐥𝐚𝐫 𝐜𝐨𝐧𝐬𝐮𝐦𝐩𝐭𝐢𝐨𝐧 𝐦𝐚𝐲 𝐛𝐞 𝐧𝐞𝐞𝐝𝐞𝐝 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐚𝐥𝐥𝐞𝐫𝐠𝐞𝐧 𝐭𝐨𝐥𝐞𝐫𝐚𝐧𝐜𝐞.⁣

𝐓𝐡𝐢𝐬 𝐦𝐞𝐚𝐧𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐨𝐮𝐥𝐝 𝐧𝐞𝐞𝐝 𝐭𝐨 𝐭𝐚𝐤𝐞 𝐭𝐡𝐞 𝐦𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐚 𝐝𝐚𝐢𝐥𝐲 𝐛𝐚𝐬𝐢𝐬 𝐨𝐫 𝐭𝐡𝐞𝐫𝐞 𝐰𝐢𝐥𝐥 𝐛𝐞 𝐫𝐞𝐯𝐞𝐫𝐬𝐚𝐥 𝐨𝐟 𝐬𝐲𝐦𝐩𝐭𝐨𝐦𝐬. 𝐀𝐧𝐝 𝐭𝐡𝐢𝐬 𝐰𝐚𝐬 𝐚𝐥𝐫𝐞𝐚𝐝𝐲 𝐩𝐫𝐨𝐯𝐞𝐧 𝐢𝐧 𝐚 𝐫𝐞𝐜𝐞𝐧𝐭 𝐬𝐭𝐮𝐝𝐲.⁣
⁣
➡️To consider that AR101 will cost between $5000 to $10,000 for the first six months of use, and $300 to $400 per month after that.

business.facebook.com/permalink.php?story_fbid=127750235721885&id=109164090913833&__xts__%5B0%5D=68.ARAcfMWkVnUYwR3FN5rBEi1F6d1taXQUPf2mIqFAwrdVoz0OQ8C7KC9BEkUugTY4VILoskwaZxhM3o5A4nnmtOsx9FOBpYBNncpP66MpqQQKTWwKtXQzHy-vHURBMsvP6nE0Bxmspsh_DrjVT7LJ22qsDgJ52vrZLmGVNG1cD6RBmBLxJYmz3i_42bVVB7ughQOfl9qp33AIFWM6H_x8IGbSwGERKrEayt-OEsJB4AAY9A6AugvMfFZLkpgJUi8PLCcSObCm0FFjd9ORotB_K4jeKFfDGc1E0jY03B-7K6b4RkT7QrvqbW6PyYQ3PwTDXsw&__tn__=-R-R

0 Comments

    Author

    Dr Costa is a Consultant Paediatrician and fellow of the Royal College of Paediatrics and Child Health.

    Archives

    February 2021
    January 2021
    November 2020
    September 2020
    August 2020
    June 2020

    Categories

    All
    Airborne Allergies
    Allergens
    Allergic Rhinitis
    Allergy To Pets
    Asthma
    Breast Milk
    Chicken
    Chicken Allergy
    Coeliac Disease
    COVID19 Vaccine
    Cow's Milk Protein Allergy
    Dinosaur
    Eczema
    Egg
    Egg Allergy
    Egg Ladder
    Flu Vaccine
    Food Allergy
    Food Protein Induced Enterocolitis Syndrome
    Food Protein Induced Proctocolitis
    FPIES
    FPIP
    Gastroesophageal Reflux
    Gastroesophageal Reflux Disease
    GER
    GERD
    Guest Blog
    Hayfever
    Immunotherapy
    Lactose Intolerance
    Mast Cell Activation Syndrome
    MMR Vaccine
    Non Allergic Rhinitis
    Oral Allergy Syndrome
    Oxford AstraZeneca Vaccine
    Peanut Allergy
    Pfizer Vaccine
    Pollen Food Syndrome
    Rabies Vaccine
    Vaccination
    Weaning
    Wheat Allergy
    Yellow Fever Vaccine

    RSS Feed

Clinic Address: The Chase, Old Milverton Ln, Leamington Spa CV32 6RW
Email address: officedrcosta@gmail.com
​Contact number: 07949990798


Website design & content by LIT Communication: www.litcommunication.com
Picture
  • Home
  • About
  • Services
    • Types of Allergy
    • Fees
  • Resources
  • Blog
  • Contact